GLP-1 and exercise don't have to feel overwhelming. Learn how to move safely, build strength, and support long-term results.
BioMarin Pharmaceutical (NASDAQ:BMRN) executives highlighted a three-pillar strategy focused on growth, innovation, and “value commitment” during a fireside chat hosted by Leerink Partners’ Joe ...
Deramiocel BLA for Duchenne muscular dystrophy under U.S. FDA review with PDUFA target action date of August 22, 2026Pivotal ...